Achieve Life Sciences, Inc. (NASDAQ:ACHV) has a beta value of 1.41 and has seen 1,093,646 shares traded in the recent trading session. The company, currently valued at $14.66 Million, closed the recent trade at $0.3895 per share which meant it lost $0 on the day or 0.7% during that session. The ACHV stock price is -544.42% off its 52-week high price of $2.51 and 40.95% above the 52-week low of $0.23. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.78 Million shares traded. The 3-month trading volume is 980.42 Million shares.

Achieve Life Sciences, Inc. (NASDAQ:ACHV) trade information

Despite being -0.03% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the ACHV stock price touched $0.43 or saw a rise of 10.26%. Year-to-date, Achieve Life Sciences, Inc. shares have moved -27.17%, while the 5-day performance has seen it change -8.99%. Over the past 30 days, the shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) have changed -5.49%. Short interest in the company has seen 2.2 Million shares shorted with days to cover at 0.

Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 1440.44% from current levels. The projected low price target is $2 while the price target rests at a high of $10. In that case, then, we find that the current price level is +2467.39% off the targeted high while a plunge would see the stock lose 413.48% from current levels.

Achieve Life Sciences, Inc. (ACHV) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +58.4% over the past 5 years. Earnings growth for 2020 is a modest +45% while over the next 5 years, the company’s earnings are expected to increase by 0%.